Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study aims to evaluate the comparative risk of dementia/Alzheimer\'s disease onset between patients treated with medications that target specific metabolic pathways and patients treated with alternative medications for the same indication.
Epistemonikos ID: 6aab12fc78275f9ab0a3dbdbd9eaae532256fb5b
First added on: May 14, 2024